mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml
As listed in the register: mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion
0.10 mg/ml ·
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- MRNA-1345
- Made by
- Moderna Switzerland GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- mRESVIA ist indiziert für die aktive Immunisierung zur Prävention von durch das Respiratorische Synzytial-Virus (RSV) verursachten Erkrankungen der unteren Atemwege (lower respiratory tract disease, LRTD) von: Erwachsenen im Alter von 60 Jahren und älter Erwachsenen im Alter von 18 bis 59 Jahren mit erhöhtem Risiko für eine durch RSV verursachte LRTD.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Moderna Switzerland GmbH |
|---|---|
| Active substance | MRNA-1345 |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 0.10 mg/ml |
| Classification | J07BX05 · Antibiotics, antivirals and antifungals taken into the body |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion |
| Packs | 1 Fertigspritze(n) · 10 Fertigspritze(n) |
| Zulassungsnummer | 69995 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.